InChI=1S/C26H45NO20/c1- 6- 12(32) 15(35) 17(37) 25(41- 6) 46- 21- 11(27- 7(2) 31) 24(47- 22- 14(34) 9(4- 29) 42- 23(40) 19(22) 39) 44- 10(5- 30) 20(21) 45- 26- 18(38) 16(36) 13(33) 8(3- 28) 43- 26/h6,8- 26,28- 30,32- 40H,3- 5H2,1- 2H3,(H,27,31) /t6- ,8+,9+,10+,11+,12+,13- ,14- ,15+,16- ,17- ,18+,19+,20+,21+,22- ,23?,24- ,25- ,26- /m0/s1 |
SFZBBUSDVJSDGR-LVDSFCAASA-N |
C[C@@H] 1O[C@@H] (O[C@@H] 2[C@@H] (NC(C) =O) [C@H] (O[C@@H] 3[C@@H] (O) C(O) O[C@H] (CO) [C@@H] 3O) O[C@H] (CO) [C@H] 2O[C@@H] 2O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H] 2O) [C@@H] (O) [C@H] (O) [C@@H] 1O |
|
Outgoing
|
β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcpNAc- (1→3)- D- Galp
(CHEBI:153716)
is a
amino tetrasaccharide
(CHEBI:59412)
β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcpNAc- (1→3)- D- Galp
(CHEBI:153716)
is a
glucosamine oligosaccharide
(CHEBI:22485)
|
|
6- deoxy- α- L- galactopyranosyl- (1→3)- [β- D- galactopyranosyl- (1→4)]- 2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→3)- D- galactopyranose
|
6- deoxy- alpha- L- galacto- hexopyranosyl- (1→3)- [beta- D- galacto- hexopyranosyl- (1→4)]- 2- acetamido- 2- deoxy- beta- D- gluco- hexopyranosyl- (1→3)- D- galacto- hexopyranose
|
SUBMITTER
|
α- L- fucopyranosyl- (1→3)- [β- D- galactopyranosyl- (1→4)]- 2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→3)- D- galactopyranose
|
IUPAC
|
β- D- galactosyl- (1→4)- [α- L- fucosyl- (1→3)]- N- acetyl- β- D- glucosaminyl- (1→3)- D- galactose
|
ChEBI
|
Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-3)Gal
|
SUBMITTER
|
Fucα1-3[Galβ1-4]GlcNacβ1-3Gal
|
IUPAC
|
Galβ1,4[Fucα1,3]GlcNacβ1,3Gal
|
ChEBI
|
N- [(2S,3R,4R,5S,6R)- 6- (Hydroxymethyl)- 5- [(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxy- 2- [(3R,4S,5S,6R)- 2,3,5- trihydroxy- 6- (hydroxymethyl)oxan- 4- yl]oxy- 4- [(2S,3S,4R,5S,6S)- 3,4,5- trihydroxy- 6- methyloxan- 2- yl]oxyoxan- 3- yl]acetamide
|
IUPAC
|
WURCS=2.0/4,4,3/[a2112h- 1x_1- 5][a2122h- 1b_1- 5_2*NCC/3=O][a1221m- 1a_1- 5][a2112h- 1b_1- 5]/1- 2- 3- 4/a3- b1_b3- c1_b4- d1
|
SUBMITTER
|
2580573
|
PubMed citation
|
Europe PMC
|
|